Peregrine Pharma (PPHM) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
MOGU, JFIN, ACON, More
Financial Fact:
Contract manufacturing revenue: 5.61M
Today's EPS Names:
MOGU, JFIN, ACON, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.75 million versus the consensus estimate of $14 million.
GUIDANCE:
Peregrine Pharma sees FY2017 revenue of $60-65 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Gap, Inc. (GAP) Tops Q2 EPS by 3c
- SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
- Workday (WDAY) Tops Q2 EPS by 14c; offers outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
